You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 150 No. 1, January 1996 TABLE OF CONTENTS
  Archives
  •  Online Features
  Articles
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Diagnosis of Pediatric Human Immunodeficiency Virus Infection by Means of a Commercially Available Polymerase Chain Reaction Gene Amplification

Robert P. Nelson, Jr, MD; Lorinda J. Price, MD, MPH; Alan B. Halsey, MD; Stanley N. Graven, MD; Lionel Resnick, MD; Noorbibi K. Day, PhD; Richard F. Lockey, MD; Robert A. Good, MD, DSc

Arch Pediatr Adolesc Med. 1996;150(1):40-45.


Abstract

Objective
To assess the sensitivity and specificity of polymerase chain reaction (PCR) in infants and children at risk for human immunodeficiency virus (HIV) infection.

Design
A prospective, blinded study of 286 HIV-seropositive infants and children. Infection was diagnosed by antibody detection after 18 months of age, two positive direct tests (p24 antigen and HIV culture), or the presence of an illness that defines the acquired immunodeficiency syndrome.

Setting
University of South Florida and All Children's Hospital, St Petersburg, inpatient and outpatient centers.

Participants
Two hundred eighty-six infants and children seropositive for HIV who were examined between July 1988 and September 1992.

Main Outcome Measures
Sensitivity, specificity, and predictive values of a commercially available PCR test.

Results
Five hundred sixty-seven PCR tests were performed on samples from 286 seropositive subjects followed up for a minimum of 16 months. Of the subjects, 105 were confirmed to be infected and 181 uninfected. Overall, 96 of 105 initial PCRs in infected subjects were positive (sensitivity, 91.4%; positive predictive value, 99%). If samples obtained during the first week of life are excluded, 95 of 100 samples were positive (sensitivity, 95%). Of 181 initial PCR tests from seropositive subjects who seroreverted, 180 were negative (specificity, 99.4%; negative predictive value, 95.2%). The predictive value of a positive test was 90.9% and that of a negative test was 93.1% in the first month of life. All 145 initial samples obtained between 5 weeks and 12 months of age correctly predicted infection status (positive predictive value, 100%).

Conclusions
Gene amplification by means of a commercially available PCR is useful in the diagnosis of HIV infection for infants born to seropositive mothers. Between day 7 through 1 year of age, HIV infection is accurately diagnosed by the PCR assay.

(Arch Pediatr Adolesc Med. 1996;150:40-45)



Author Affiliations

From the Departments of Pediatrics, University of South Florida College of Medicine, St Petersburg (Drs Nelson, Price, Halsey, Graven, Day, Lockey, and Good), and Mount Sinai Medical Center, Miami Beach, Fla (Dr Resnick).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Diagnosis of HIV-1 Infection in Children Younger Than 18 Months in the United States
Read and and the Committee on Pediatric AIDS
Pediatrics 2007;120:e1547-e1562.
ABSTRACT | FULL TEXT  

The Impact of Expected HIV Transmission Rates on the Effectiveness and Cost of Ruling Out HIV Infection in Infants
Mrus et al.
Med Decis Making 2002;22:S38-S44.
ABSTRACT  

In Search of the Holy Grail
Oleske
Arch Pediatr Adolesc Med 1996;150:39-39.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.